Successful living donor liver transplantation in a patient with hemophilia A and factor VIII inhibitor: A case report with perioperative recommendations

Am J Transplant. 2023 Jun;23(6):839-843. doi: 10.1016/j.ajt.2023.02.026. Epub 2023 Mar 9.

Abstract

Liver transplantation in patients with end-stage liver disease and coexisting hemophilia A has been described. Controversy exists over perioperative management of patients with factor VIII inhibitor predisposing patients to hemorrhage. We describe the case of a 58-year-old man with a history of hemophilia A and factor VIII inhibitor, eradicated with rituximab prior to living donor liver transplantation without recurrence of inhibitor. We also provide perioperative management recommendations from our successful multidisciplinary approach.

Keywords: factor inhibitor; hemophilia; living donor liver transplant; remission.

Publication types

  • Case Reports

MeSH terms

  • Factor VIII / therapeutic use
  • Hemophilia A* / complications
  • Hemophilia A* / surgery
  • Humans
  • Liver Transplantation* / adverse effects
  • Living Donors
  • Male
  • Middle Aged
  • Rituximab

Substances

  • Factor VIII
  • Rituximab